Substituted 1,4-dihydropyridines and their use as medicaments

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546277, 546256, 546257, 546258, 546280, 514340, 514333, C07D41304, A61K 3144

Patent

active

045580588

ABSTRACT:
1,4-dihydropyridines of the formula I ##STR1## in which R denotes, for example, --CO.sub.2 R.sup.3 or cyano, R.sup.1 denotes, for example, an optionally substituted phenyl, pyridyl or thienyl, R.sup.2 denotes the radical of a 5-membered, optionally substituted, ring having at least one double bond and at least 2 heteroatoms or heteroatom groups from the series comprising O, N, NH and S, and R.sup.3 denotes, for example, alkyl or alkoxyalkyl, and their acid addition salts, have valuable pharmacological properties.

REFERENCES:
patent: 4144343 (1979-03-01), Baldwin
patent: 4145432 (1979-03-01), Sato
patent: 4260765 (1981-04-01), Harrison
patent: 4414213 (1983-11-01), Poindexter
Chemical Abstracts, vol. 93, No. 23, 220596j, 12/8/80, (Bayer).
Chemical Abstracts, vol. 94, No. 11, 83961d, 3/16/81, (Institute of Organic Synthesis).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 1,4-dihydropyridines and their use as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 1,4-dihydropyridines and their use as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,4-dihydropyridines and their use as medicaments will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-59124

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.